Boston Oncology
Pre-clinicalBold and nimble, Boston Oncology is an innovative biogenerics company redefining excellence in the licensing and local development
Founded
2018
Focus
Generic Drugs
About
Bold and nimble, Boston Oncology is an innovative biogenerics company redefining excellence in the licensing and local development
Funding History
2Total raised: $33M
Series A$25MMorningside VenturesFeb 15, 2023
Seed$8MUndisclosedSep 15, 2021
Company Info
TypePrivate
Founded2018
LocationBoston, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile